Table 2.
Predictive factors of survival.
| Predictive factors | Number of patients | Overall survival | Disease-free survival | ||
|---|---|---|---|---|---|
| 5-year survival (%) | P | 5-year survival (%) | P | ||
| Age | |||||
| <60 years | 180 | 36.1 | P = .002 | 27.7 | P = .68 |
| ≥60 years | 160 | 26.1 | 26.9 | ||
|
| |||||
| Menopausal status | |||||
| No | 95 | 43.7 | P = .001 | 31.5 | P = .128 |
| Yes | 237 | 36.4 | 25.4 | ||
|
| |||||
| Residual disease after surgery | |||||
| <1 cm (without residual disease) | 135 (69) | 43.5 (55.4) | P = .0002 | 27.6 (40.6) | P = .58 |
| ≥1 cm | 204 | 24.2 | 26.7 | ||
|
| |||||
| Lymph node dissection (picking) | |||||
| No | 279 | 29 | P = .02 | 24.8 | P = .01 |
| Yes | 61 | 42.5 | 37.8 | ||
|
| |||||
| FIGO stage | |||||
| III | 264 | 34.6 | P = .002 | 25.7 | P = .15 |
| IV | 76 | 19.1 | 33.6 | ||
|
| |||||
| Histology | |||||
| Serous | 277 | 31.2 | 26.3 | ||
| Mucinous | 9 | 22.2 | P = .005 | 48.6 | P = .0007 |
| Endometrioid | 26 | 45.0 | 42.9 | ||
| Clear cell | 4 | 25.0 | 25.0 | ||
| Undifferentiated | 12 | 38.9 | — | ||
| Other | 12 | 8.3 | — | ||
|
| |||||
| Grade (2 classes) | |||||
| 1 | 13 | 58.6 | P = .005 | 60.0 | P = .05 |
| 2 and 3 | 140 | 24.8 | 16.0 | ||
|
| |||||
| Chemotherapy | |||||
| Platinum and alkylating agents | 217 | 30.3 | P = .107 | 38.2 | P = .02 |
| Platinum and Paclitaxel | 116 | 34.6 | 26.7 | ||
NS = not significant.